只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-04 2026-06-05 | UMAC Unusual Machines, Inc. | Camden Andrew Ross Officer · President | 卖出（S） | 100,000 | US$30.05 | US$300.5万 | 246,750 | SEC |
| 2026-06-01 2026-06-02 | UMAC Unusual Machines, Inc. | Rich Sanford Director | 卖出（S） | 25,000 | US$28.98 | US$724,500.00 | 182,317 | SEC |
| 2026-05-27 2026-05-29 | UMAC Unusual Machines, Inc. | Hoff Brian Joseph Officer · Chief Financial Officer | 卖出（S） | 150,000 | US$17.71 | US$265.65万 | 352,650 | SEC |
| 2026-05-21 2026-05-22 | UMAC Unusual Machines, Inc. | Hoff Brian Joseph Officer · Chief Financial Officer | 卖出（S） | 11,412 | US$14.17 | US$161,708.04 | 502,650 | SEC |
| 2026-05-21 2026-05-22 | UMAC Unusual Machines, Inc. | Rich Sanford Director | 卖出（S） | 1,392 | US$14.18 | US$19,738.56 | 207,317 | SEC |
| 2026-05-21 2026-05-22 | UMAC Unusual Machines, Inc. | Camden Andrew Ross Officer · President | 卖出（S） | 9,625 | US$14.18 | US$136,482.50 | 346,750 | SEC |
| 2026-05-19 2026-05-20 | HUMA Humacyte, Inc. | Sebelius Kathleen Director | 买入（P） | 56,818 | US$0.88 | US$49,999.84 | 148,025 | SEC |
| 2026-05-18 2026-05-20 | HUMA Humacyte, Inc. | Constantino Michael T. Director | 买入（P） | 11,000 | US$0.89 | US$9,790.00 | 43,950 | SEC |
| 2026-05-18 2026-05-20 | HUMA Humacyte, Inc. | Sander Dale A. Officer · CFO and Chief Corp. Dev. Off | 卖出（S） | 45,887 | US$0.90 | US$41,298.30 | 267,213 | SEC |
| 2026-05-18 2026-05-20 | HUMA Humacyte, Inc. | Parikh Shamik J Officer · Chief Medical Officer | 卖出（S） | 45,887 | US$0.90 | US$41,298.30 | 272,713 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| UMAC | 810,236.0663 | 4,785 | 1,382,787.9379 | 58.59% | B, Q, N |